![P4A Let's Talk Rare: The Life Science Podcast](https://d3jbilhebgld9z.cloudfront.net/podcasts/p4a_lets_talk_rare/images/hero.jpg)
P4A Let's Talk Rare: The Life Science Podcast
Welcome to P4A Let’s Talk Rare, a monthly podcast highlighting the most important developments in the world of rare diseases orphan drug, cell and gene therapy, hosted by Georgie Rack and Owen Bryant of Partners For Access. To find out more about Partners For Access and our commitment to sustainable
...more
Science
Impact of Mergers, Acquisitions, and Patent Expirations on Job Cuts in Pharma and Biotech: Insights from Aurelija L...
Welcome to this month's episode of the P4A Let’s Tal...
more
Jul 2 2024 27m
The Role of Patient Experience Data in Drug Development with Pina Haberl and Sam Morrison
Welcome to this month's episode of the P4A Let’s T...
more
May 2 2024 34m
World EPA Conference 2024 Special
Welcome to this month's episode of Let’s Talk Rare: ...
more
Apr 10 2024 28m
The Role of Genetic Diagnoses in Rare Conditions with Nick Meade
Welcome to this month's episode of the Let’s Talk Ra...
more
Feb 29 2024 24m
Celebrating 5 Years of P4A: Reflections on Rare Diseases, Cell and Gene Therapies, and Legislation in Europe
Hello and welcome to this special episode of Let’s...
more
Jan 2 2024 53m
Revolutionizing Patient Outcomes: The Power of Digital Health Solutions with RJ Kedziora
In this podcast, Georgie, RJ, and Owen discuss revol...
more
Dec 1 2023 28m
The Future of Patient Engagement and the Role of Technology in Healthcare with Iola Forster
Welcome to this month's episode of the Let’s Talk Ra...
more
Oct 6 2023 23m
Navigating the New EU HTA Regulation and Its Impact on ATMP Development
Welcome to this month's episode of the Let’s Talk R...
more
Jul 31 2023 16m
Alejandro Dorenbaum, CMO of Reneo Pharmaceuticals Discusses Clinical-Stage Therapies
In this episode we will be talking to Alejandro (Al...
more
Jun 1 2023 16m
Interview with Xortx Therapeutics CEO, Dr Allen Davidoff discussing their journey from early development to potenti...
P4A are joined by Xortx Therapeutics' CEO, Dr Allen ...
more
Apr 29 2023 19m
World EPA Congress 2023 Special
P4A host a special episode live from World Evidence,...
more
Apr 17 2023 24m
Rare Disease Day Special 2023
In this episode of Let’s Talk Rare, as we commemorat...
more
Feb 28 2023 40m
Trends to look out for in 2023
The P4A team have hand-picked trends to look out for...
more
Feb 3 2023 44m
World Orphan Drug Congress Europe 2022 Special
Did you miss the World Orphan Drug Congress Europe 2...
more
Dec 20 2022 42m
Winds of change for German Healthcare Market!
Winds of change are howling in Germany, with t...
more
Oct 31 2022 38m
Part 2 -Patient Empowerment: Is it a no-brainer?
P4A’s 2 part -Patient Empowerment podcast series has...
more
Oct 3 2022 28m
Part 1 Patient Empowerment; Why involving patients from early drug development through to launch is a no-brainer!
This month we have a special 2-part series focused o...
more
Sep 13 2022 31m
What makes P4A an award winning consultancy?
This month we have put together a slightly different...
more
Jul 29 2022 15m
Special Episode with EUCOPE-Part 2 with Alexander Natz
In this episode Chloe & Alexander will be starti...
more
Jun 30 2022 28m
Special series with Eucope: Part 1 featuring Victor Maertens
Part 1 featuring Victor Maertens, Government Affairs...
more
May 31 2022 24m
China market access: obstacle or opportunity for orphan drug, cell and gene therapy manufacturers?
In 2020 China’s pharmaceutical market passed an impo...
more
Apr 29 2022 10m
Should the Middle East be a priority launch market for orphan drug manufacturers?
Over the last few years, the Middle East has piqued ...
more
Mar 31 2022 12m
Rare Disease Day Special featuring Janet Bloor and Nick Meade - February 2022
For this Rare Disease Day episode, Janet and Nick di...
more
Feb 28 2022 28m
P4A Insights: Trends to look out for in 2022
Lots of anticipated changes are expected in the orph...
more
Feb 4 2022 10m
Special episode - Bluebird Bio: What went wrong? -December 2021:
Sophie Schmitz and Joanna Fernandes discuss bluebird...
more
Dec 13 2021 17m